NCT01059578 - First Study in Humans With GSK206136 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 23, 2006

Primary Completion Date

December 18, 2006

Study Completion Date

December 18, 2006

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG

GSK206136

GSK206136 2mg, 10mg, 50mg, 100mg capsule

DRUG

PLACEBO

Placebo to match 206136 2mg, 10mg, 50mg, 100mg capsule

RADIATION

PET

Each subject will undergo 3 PET Scans ; one at Baseline and the others following dosing with GSK206136 at approximately 2 hours post-dose and 24 hours post-dose

Trial Locations (1)

SE1 1YR

GSK Investigational Site, London